Announcements Trials

Browse Landscape

Phase

Status

Completed 210 Recruiting 80 Active not recruiting 70 Unknown 61 Terminated 56 Withdrawn 16 Not yet recruiting 15 Enrolling by invitation 2 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Carcinoma In Situ 1

Interventions

Specimen Handling 29 Magnetic Resonance Spectroscopy 18 Biopsy 16 Cyclophosphamide 15 Nivolumab 10 Paclitaxel 9 Vincristine 8 Cisplatin 8 venetoclax 7 Prednisone 7 Gemcitabine 7 Doxorubicin 7 Bevacizumab 7 Azacitidine 7 pembrolizumab 6 Radiotherapy 6 Fluorouracil 6 Etoposide 6 Drug Therapy 6 Docetaxel 6 Rituximab 5 Radiosurgery 5 Oxaliplatin 5 Irinotecan 5 Injections 5 Everolimus 5 Capecitabine 5 fludarabine phosphate 4 Taxes 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Interventional × Letrozole × Clear all

NCT06671912 2026-05-08

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡